Brix Susanne, Bovetto Lionel, Fritsché Rodolphe, Barkholt Vibeke, Frøkiaer Hanne
BioCentrum-DTU, Technical University of Denmark, Lyngby, Denmark.
J Allergy Clin Immunol. 2003 Dec;112(6):1216-22. doi: 10.1016/j.jaci.2003.08.047.
The immunomodulating potential residing in cow's milk proteins is currently receiving increasing attention because of growing interest in functional foods and the complex problem of cow's milk allergy. One of the major cow's milk allergens, whey protein beta-lactoglobulin, has previously been shown to mediate cellular activation in both human and murine immune cells.
We examined the response to different beta-lactoglobulin preparations in naive immune cells.
Splenocytes and cells from mesenteric lymph nodes derived from BALB/c mice bred and maintained on a milk-free diet were cultured in vitro with different beta-lactoglobulin preparations. Cell proliferation, cytokine production, and increases in intracellular glutathione were used as cellular activation markers. Moreover, the effect of beta-lactoglobulin on cytokine production in murine bone-marrow-derived dendritic cells was examined.
We observed that some commercial beta-lactoglobulin preparations induced pronounced proliferation of both spleen cells and cells from mesenteric lymph nodes; production of TNF-alpha, IL-6, IL-1beta, and IL-10; and an increased level of intracellular glutathione in spleen cell cultures. Furthermore, TNF-alpha, IL-6, IL-1beta, and IL-10 production was induced in murine bone-marrow-derived dendritic cells. Purification of beta-lactoglobulin from raw milk using nondenaturating conditions, however, revealed that the beta-lactoglobulin per se did not possess the immunomodulatory activity. Eventually, the immunostimulatory effect was found to be caused by endotoxin contamination.
These results identify endotoxin as the main immunostimulatory component present in some commercial beta-lactoglobulin preparations. Moreover, the present study makes it evident that immunomodulatory effects attributed to beta-lactoglobulin need to be reassessed.
由于对功能性食品的兴趣日益浓厚以及牛奶过敏这一复杂问题,牛奶蛋白中的免疫调节潜力目前正受到越来越多的关注。牛奶的主要过敏原之一,乳清蛋白β-乳球蛋白,先前已被证明可介导人类和小鼠免疫细胞的细胞活化。
我们研究了未致敏免疫细胞对不同β-乳球蛋白制剂的反应。
将饲养于无牛奶饮食的BALB/c小鼠的脾细胞和肠系膜淋巴结细胞与不同的β-乳球蛋白制剂进行体外培养。细胞增殖、细胞因子产生以及细胞内谷胱甘肽的增加被用作细胞活化标记。此外,还研究了β-乳球蛋白对小鼠骨髓来源树突状细胞细胞因子产生的影响。
我们观察到一些商业β-乳球蛋白制剂可诱导脾细胞和肠系膜淋巴结细胞显著增殖;产生肿瘤坏死因子-α、白细胞介素-6、白细胞介素-1β和白细胞介素-10;并使脾细胞培养物中的细胞内谷胱甘肽水平升高。此外,在小鼠骨髓来源的树突状细胞中也诱导产生了肿瘤坏死因子-α、白细胞介素-6、白细胞介素-1β和白细胞介素-10。然而,使用非变性条件从原料奶中纯化β-乳球蛋白后发现,β-乳球蛋白本身不具有免疫调节活性。最终发现免疫刺激作用是由内毒素污染引起的。
这些结果确定内毒素是一些商业β-乳球蛋白制剂中存在的主要免疫刺激成分。此外,本研究表明,归因于β-乳球蛋白的免疫调节作用需要重新评估。